Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
ics PLC - Sussex, England-based biotechnology company - Treats its first patient in the third phase of its paediatric ...
Allergy Therapeutics PLC 27 November 2024 Allergy Therapeutics plc ("Allergy Therapeutics", "ATL" or the "Group") Allergy Therapeutics announces first patient treated in G308 Phase III...
Allergy Therapeutics PLC 25 November 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group") Allergy Therapeutics Submits Marketing Authorisation Application for Grass MATA...
Allergy Therapeutics PLC 21 November 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company") Notice of 2024 Annual General Meeting 21 November 2024 - Allergy...
Allergy Therapeutics PLC on Wednesday said it narrowed its loss during its most recent financial year despite a decli ...
Allergy Therapeutics PLC 06 November 2024 Allergy Therapeutics PLC ("Allergy Therapeutics" or the "Group") Audited Preliminary Results for the Year ended 30 June 2024 - ...
Allergy Therapeutics PLC on Monday revealed that the first candidates have been enrolled in its phase III paediatric ...
Allergy Therapeutics PLC 21 October 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group") Allergy Therapeutics commences Phase III paediatric trial for Grass MATA MPL ...
Allergy Therapeutics PLC shares rallied on Wednesday after it announced a funding update with an alternative asset ma ...
Allergy Therapeutics PLC 16 October 2024 Allergy Therapeutics plc ("Allergy Therapeutics", the "Group" or "Company") Update on funding 16 October 2024 Allergy Therapeutics plc (AIM:...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -0.952380952381 | 5.25 | 5.55 | 5.06 | 571130 | 5.25784236 | DE |
| 4 | 0.2 | 4 | 5 | 5.62 | 5 | 417727 | 5.36540699 | DE |
| 12 | 1.15 | 28.3950617284 | 4.05 | 5.62 | 3.95 | 369380 | 4.97579521 | DE |
| 26 | 1.15 | 28.3950617284 | 4.05 | 6.05 | 3.88 | 494371 | 5.13486331 | DE |
| 52 | 3.25 | 166.666666667 | 1.95 | 6.05 | 1.88 | 669949 | 3.57861645 | DE |
| 156 | -30.3 | -85.3521126761 | 35.5 | 35.5 | 0.85 | 495857 | 4.28819517 | DE |
| 260 | -6.3 | -54.7826086957 | 11.5 | 40 | 0.85 | 432930 | 9.144809 | DE |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
